Urinary Tract Infections (UTI) Therapeutics - Pipeline

Assessment and Market Forecasts to 2018

On 18thNovember 2014

Summary
The industry analysis specialist, has released its new report, Urinary Tract Infections (UTI)
Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The report is an essential
source of information and analysis on the global Urinary Tract Infections Therapeutics market.
The report identifies the key trends shaping and driving the global Urinary Tract Infections
Therapeutics market. The report also provides insights on the prevalent competitive landscape
and the emerging players expected to significantly alter the market positioning of the current
market leaders. Most importantly, the report provides valuable insights on the pipeline
products within the global Urinary Tract Infections Therapeutics sector. This report is built using
data and information sourced from proprietary databases, primary and secondary research and
in-house analysis by GlobalDatas team of industry experts.

Browse Full Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-urinary-tract-infections-uti-therapeutics-pipeline-assessment-andmarket-forecasts-135250

Scope
The report provides information on the key drivers and challenges of the Urinary Tract
Infections Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Urinary Tract
Infections Therapeutics market revenues data from 2005 to 2010, forecast for eight years to
2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Urinary Tract
Infections Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Urinary Tract Infections Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Urinary Tract Infections
Therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Urinary Tract Infections Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Urinary Tract Infections
Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Whats the next big thing in the global Urinary Tract Infections Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 UTI Therapeutics - Introduction
2.1 Overview
2.2 Classification of UTI
2.2.1 Site of Infection
2.2.2 Based On Symptoms
2.2.3 Based on Recurrence
2.2.4 Based on Complicating Factors
2.2.5 Based on Origin of Infection
2.3 Epidemiology
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.4 Etiology
2.5 Risk Factors
2.6 Signs and Symptoms
2.7 Pathophysiology of UTI
2.8 Diagnosis and Treatment of UTI
2.9 GlobalData Pipeline Report Guidance
3 UTI Therapeutics - Market Characterization
3.1 UTI Therapeutics Market Size (2005-2010) - Global
3.2 UTI Therapeutics Market Forecast (2010-2018) - Global
3.3 UTI Therapeutics Market Size (2005-2010) - The US
3.4 UTI Therapeutics Market Forecast (2010-2018) - The US
3.5 UTI Therapeutics Market Size (2005-2010) - France
3.6 UTI Therapeutics Market Forecast (2010-2018) - France
3.7 UTI Therapeutics Market Size (2005-2010) - Germany
3.8 UTI Therapeutics Market Forecast (2010-2018) - Germany
3.9 UTI Therapeutics Market Size (2005-2010) - Italy
3.10 UTI Therapeutics Market Forecast (2010-2018) - Italy
3.11 UTI Therapeutics Market Size (2005-2010) - Spain
3.12 UTI Therapeutics Market Forecast (2010-2018) - Spain
3.13 UTI Therapeutics Market Size (2005-2010) - The UK
3.14 UTI Therapeutics Market Forecast (2010-2018) - The UK
3.15 UTI Therapeutics Market Size (2005-2010) - Japan
3.16 UTI Therapeutics Market Forecast (2010-2018) - Japan
3.17 Drivers and Barriers for the UTI Therapeutics Market
3.17.1 Drivers for the UTI Therapeutics Market
3.17.2 Barriers for the UTI Therapeutics Market
3.18 Key Events Impacting the Future Market
3.19 Opportunity and Unmet Need
3.20 Key Takeaway
4 UTI Therapeutics Market - Competitive Assessment
4.1 Overview
4.1.1 Strategic Competitor Assessment
4.2 Profiles of Commonly Used Products in the UTI Therapeutics Market
4.2.1 Ciprofloxacin
4.2.2 Doribax (doripenem)
4.2.3 Invanz (ertapenem sodium)
4.2.4 Levaquin (levofloxacin)
4.2.5 Fosfomycin tromethamine
4.2.6 Macrobid/Macrodantin (nitrofurantoin)
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

4.2.7 Bactrim/Septra (trimethoprim/sulfamethoxazole)

4.3 Key Takeaway
5 UTI Therapeutics Market - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.2.1 UTI Therapeutics - Phase III Pipeline
5.2.2 UTI Therapeutics - Phase II Pipeline
5.2.3 UTI Therapeutics Phase I Pipeline
5.3 UTI Pipeline by Mechanism of Action
5.4 UTI Technology Trends Analytical Framework
5.5 UTI Therapeutics - Late-stage Drugs under Clinical Development
5.6 Molecule Profile for Late-stage Drugs under Clinical Development
5.6.1 CXA-201 (CXA-101/tazobactam)
5.6.2 CAZ-AVI (Avibactam/ceftazidime)
5.7 Key Takeaway
6 UTI Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Country (US, EU5 and Japan)
6.2 Clinical Trials by Phase
6.3 Clinical Trials by Trial Status
6.4 Overall Sponsors
6.5 Prominent Sponsors
6.6 Top Companies Participating in UTI Therapeutics Clinical Trials
7 UTI Therapeutics - Strategic Assessment
7.1 UTI Therapeutics - Implications for Future Market Competition
8 UTI Therapeutics - Future Players
8.1 Introduction
8.1.1 AstraZeneca PLC
8.1.2 Cubist Pharmaceuticals
8.1.3 Forest Laboratories
9 UTI Therapeutics - Licensing and Partnership Deals
10 UTI Therapeutics - Appendix
10.1 Definitions
10.2 Acronyms
10.3 Research Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography
List Of Tables
Table 1: UTI - Prevalence, Major Markets, 2010
Table 2: UTI Therapeutics Market, Global, Revenue ($bn), 2005-2010
Table 3: UTI Therapeutics Market, Global, Forecast ($bn), 2010-2018
Table 4: UTI Therapeutics Market, The US, Revenue ($m), 2005-2010
Table 5: UTI Therapeutics Market, The US, Forecast ($bn), 2010-2018
Table 6: UTI Therapeutics Market, France, Revenue ($m), 2005-2010
Table 7: UTI Therapeutics Market, France, Forecast ($m), 2010-2018
Table 8: UTI Therapeutics Market, Germany, Revenue ($m), 2005-2010
Table 9: UTI Therapeutics Market, Germany, Forecast ($m), 2010-2018
Table 10: UTI Therapeutics Market, Italy, Revenue ($m), 2005-2010
Table 11: UTI Therapeutics Market, Italy, Forecast ($m), 2010-2018
Table 12: UTI Therapeutics Market, Spain, Revenue ($m), 2005-2010
Table 13: UTI Therapeutics Market, Spain, Forecast ($m), 2010-2018
Table 14: UTI Therapeutics Market, The UK, Revenue ($m), 2005-2010
Table 15: UTI Therapeutics Market, The UK, Forecast ($m), 2010-2018
Table 16: UTI Therapeutics Market, Japan, Revenue ($m), 2005-2010
Table 17: UTI Therapeutics Market, Japan, Forecast ($m), 2010-2018
Table 18: UTI Therapeutics - Phase III Pipeline
Table 19: UTI Therapeutics - Phase II Pipeline
Table 20: UTI Therapeutics Phase I Pipeline
Table 21: UTI Therapeutics - Late-stage Drugs Under Clinical Development, 2011
Table 22: UTI Therapeutics - Clinical Trials by Country, 2011
Table 23: UTI Therapeutics - Clinical Trials by Phase, 2011
Table 24: UTI Therapeutics - Clinical Trials by Status, 2011
Table 25: UTI Therapeutics, Overall Sponsors, 2011
Table 26: UTI Therapeutics - Prominent Sponsors, 2011
Table 27: UTI Therapeutics - Top Companies Participating in Clinical Trials, 2011
Table 28: AstraZeneca Infectious Disease Pipeline, 2011
Table 29: Cubist Pharmaceuticals Infectious Disease Pipeline, 2011
Table 30: Forest Laboratories - Infectious Disease Pipeline, 2011
Table 31: Licensing and Partnership Deals
List Of Figures
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 1: Classification of UTI

Figure 2: Principal Pathogens of UTI
Figure 3: Symptoms of UTI
Figure 4: Diagnostic Approach to UTI in Adults
Figure 5: Different Class of Antibiotics Used for UTI
Figure 6: Diagnosis and Treatment of UTI
Figure 7: Diagnosis and Treatment of UTI
Figure 8: UTI Therapeutics Market, Global, Revenue ($bn), 2005-2010
Figure 9: UTI Therapeutics, Market Share ($m, %), 2010
Figure 10: UTI Therapeutics Market, Global, Forecast ($bn), 2010-2018
Figure 11: UTI Therapeutics, Market Share ($m, %), 2018
Figure 12: UTI Therapeutics Market, The US, Revenue ($m), 2005-2010
Figure 13: UTI Therapeutics Market, The US, Forecast ($bn), 2010-2018
Figure 14: UTI Therapeutics Market, France, Revenue ($m), 2005-2010
Figure 15: UTI Therapeutics Market, France, Forecast ($m), 2010-2018
Figure 16: UTI Therapeutics Market, Germany , Revenue ($m), 2005-2010
Figure 17: UTI Therapeutics Market, Germany, Forecast ($m), 2010-2018
Figure 18: UTI Therapeutics Market, Italy, Revenue ($m), 2005-2010
Figure 19: UTI Therapeutics Market, Italy, Forecast ($m), 2010-2018
Figure 20: UTI Therapeutics Market, Spain, Revenue ($m), 2005-2010
Figure 21: UTI Therapeutics Market, Spain, Forecast ($m), 2010-2018
Figure 22: UTI Therapeutics Market, The UK, Revenue ($m), 2005-2010
Figure 23: UTI Therapeutics Market, The UK, Forecast ($m), 2010-2018
Figure 24: UTI Therapeutics Market, Japan, Revenue ($m), 2005-2010
Figure 25: UTI Therapeutics Market, Japan, Forecast ($m), 2010-2018
Figure 26: UTI Therapeutics Market , Key Events Impacting the Future Market
Figure 27: Opportunity and Unmet Need in the UTI Therapeutics Market, 2011
Figure 28: UTI Therapeutics - Strategic Competitor Assessment, 2011
Figure 29: UTI Therapeutics - Pipeline by Phase of Clinical Development, 2011
Figure 30: UTI Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2011
Figure 31: Technology Trends Analytical Framework of the UTI Pipeline, 2011
Figure 32: Technology Trends Analytical Framework of The UTI Therapeutics Pipeline Description, 2011
Figure 33: UTI Therapeutics - Clinical Trials by Country, 2011
Figure 34: UTI Therapeutics - Clinical Trials by Phase, 2011
Figure 35: UTI Therapeutics - Clinical Trials by Status, 2011
Figure 36: UTI Therapeutics - Overall Sponsors, 2011
Figure 37: UTI Therapeutics - Prominent Sponsors, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 38: UTI Therapeutic Clinical Trial - Company Sponsors by Phase, 2011
Figure 39: Implications for Future Market Competition in the UTI Therapeutics Market, 2011
Figure 40: UTI Therapeutics Market - Clinical Pipeline by Company, 2011
Figure 41: GlobalData Market Forecasting Model

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Related Reports:
Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Infantile Spasms Therapeutics - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

To know more on Urinary Tract Infections (UTI) Therapeutics - Pipeline

Assessment and Market Forecasts to 2018
http://www.jsbmarketresearch.com/healthcare-medical/r-urinary-tractinfections-uti-therapeutics-pipeline-assessment-and-market-forecasts-135250

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/